[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335427-105":59,"doc-detail-335427-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","association-of-metabolic-obesity-phenotypes-with-risk-of-overall-and-site-specific-cancers-a-systematic-review-and-meta-analysis-of-cohort-studies","Association of metabolic obesity phenotypes with risk of overall and site-specific cancers - a systematic review and meta-analysis of cohort studies","","Background: Adiposity is a known risk factor for certain cancers, but the cancer risk may vary according to metabolic health among people with high fatness. Objective: Evaluate associations between metabolic obesity phenotypes and overall as well as site-specific cancer risk using cohort evidence. Methods: PubMed and Embase were searched through 6 June 2023; random-effects models estimated summary relative risks with 95% CIs, and certainty was assessed via Cochrane/GRADE. Results showed higher risks for metabolically unhealthy overweight/obese compared with metabolically healthy normal-weight, with elevated site-specific cancer risks across multiple organs.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/association-of-metabolic-obesity-phenotypes-with-risk-of-overall-and-site-specific-cancers-a-systematic-review-and-meta-analysis-of-cohort-studies/335427/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/association-of-metabolic-obesity-phenotypes-with-risk-of-overall-and-site-specific-cancers-a-systematic-review-and-meta-analysis-of-cohort-studies/335427.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the systematic review and meta-analysis address?","Question",{"text":113,"@type":114},"It evaluates whether metabolic obesity phenotypes are associated differently with overall cancer risk and risk at specific cancer sites.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which study designs and data sources were used?",{"text":118,"@type":114},"Cohort studies identified from PubMed and Embase up to 6 June 2023 were included and pooled using random-effects models.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the results show for metabolically unhealthy overweight/obese individuals?",{"text":122,"@type":114},"Compared with metabolically healthy normal-weight individuals, metabolically unhealthy overweight/obese individuals had higher risks of overall and obesity-related cancers, and increased risk was observed for multiple specific cancer sites.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335427,1790418976,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www.nature.com/bjc](www.nature.com/bjc British)[ British](www.nature.com/bjc British) Journal of Cancer  \nARTICLE OPEN   \nEpidemiology  \nAssociation of metabolic obesity phenotypes with risk of overall and site-speciﬁc cancers: a systematic review and meta-analysis of cohort studies  \nYahya Mahamat-saleh 1 ✉, Dagﬁnn Aune2,3,4, Heinz Freisling 1, Sheetal Hardikar5,6, Rola Jaafar1, Sabina Rinaldi 1, Marc J. Gunter 1,2,7 and Laure Dossus 1,7  \n© The Author(s) 2024  \n\n|  | BACKGROUND: Adiposity is a known risk factor for certain cancers; however, it is not clear whether the risk of cancer differs between individuals with high adiposity but different metabolic health status. The aim of this systematic literature review and meta-analysis of cohort studies was to evaluate associations between metabolic obesity phenotypes and overall and site-speciﬁc cancer risk.\u003Cbr>METHODS: PubMed and Embase databases were used to identify relevant cohort studies up to the 6th of June 2023 . Randomeffects models were used to estimate summary relative risks (SRRs) and 95% conﬁdence intervals (CIs) for the association between metabolic obesity phenotypes and cancer risk. Certainty of evidence was assessed using the Cochrane methods and the GRADE tool. This study is registered with PROSPERO, number CRD42024549511 .\u003Cbr>RESULTS: A total of 15,556 records were screened, and 31 publications covering 15 unique cohort studies were included in this analysis. Of these studies, 22 were evaluated as being at low risk of bias and 9 at moderate risk of bias. Compared to metabolically healthy normal-weight individuals (MHNW), metabolically unhealthy overweight/obese (MUOW/OB) individuals had a higher risk of overall (SRR = 1.21, 95% CI = 1.02–1.44, n = 3 studies, high certainty) and obesity-related cancers (SRR = 1.42, 95% CI = 1.15–1.74, n = 3, very low certainty) . Speciﬁcally, MUOW/OB individuals were at higher risk of cancers of the postmenopausal breast\u003Cbr>(SRR = 1.32, 95% CI = 1.17–1.48, n = 7, low certainty), colorectum (SRR = 1.24, 95% CI = 1.16–1.31, n = 6, moderate certainty), endometrium (SRR = 2.31, 95% CI = 2.08–2.57, n = 4, high certainty), thyroid (SRR = 1.42, 95% CI = 1.29–1.57, n = 4, moderate certainty), kidney (SRR = 1.71, 95% CI = 1.40–2.10, n = 3, low certainty), pancreas (SRR = 1.35, 95% CI = 1.24–1.47, n = 3, high certainty), liver (SRR = 1.81, 95% CI = 1.36–2.42, n = 2, moderate certainty), gallbladder (SRR = 1.42, 95% CI = 1.17–1.73, n = 2, high certainty), bladder (SRR = 1.36, 95% CI = 1.19–1.56, n = 2, moderate certainty), and stomach (SRR = 1.50, 95% CI = 1.12–2.01, n = 2, high certainty) . In addition, we found elevated risks of most of these cancers among individuals classiﬁed as MUNW and MHOW/OB phenotypes compared to those with MHNW phenotype. Our stratiﬁed analyses according to metabolic obesity phenotypes suggested that the elevated risks of some cancers were stronger in individuals with MUOW/OB versus those with MHOW/OB or MUNW phenotypes.\u003Cbr>CONCLUSION: These ﬁndings suggest that both higher adiposity and metabolic dysfunction were independently associated with increased risk of several cancers, with the strongest associations generally observed among those with both metabolic dysfunction |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| and obesity. |  |  |\n|  | British Journal of Cancer (2024) 131:1480–1495; [https://doi.org/10.1038/s41416-024-02857-7](https://doi.org/10.1038/s41416-024-02857-7) |  |\n|  |  |  |\n\nINTRODUCTION  \nModiﬁable lifestyle risk factors such as smoking, alcohol, unhealthy diet, obesity, and lack of physical activity, have been estimated to cause at least 40% of cancers [1–3], and it has been suggested that about 4–8% of cancer cases are attributed to  \nexcess body weight [1–4] . ","cbCailBtee9FMhwh","https://ap.wps.com/l/cbCailBtee9FMhwh","pdf",594007,16,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What question does the systematic review and meta-analysis address?\",\"answer\":\"It evaluates whether metabolic obesity phenotypes are associated differently with overall cancer risk and risk at specific cancer sites.\"},{\"question\":\"Which study designs and data sources were used?\",\"answer\":\"Cohort studies identified from PubMed and Embase up to 6 June 2023 were included and pooled using random-effects models.\"},{\"question\":\"What did the results show for metabolically unhealthy overweight/obese individuals?\",\"answer\":\"Compared with metabolically healthy normal-weight individuals, metabolically unhealthy overweight/obese individuals had higher risks of overall and obesity-related cancers, and increased risk was observed for multiple specific cancer sites.\"}]","Association of metabolic obesity phenotypes with risk of overall and site-specific cancers - a systematic review and meta-analysis of cohort studies | PDF",1790010967]